Institutional investors purchased a net $23.8 million shares of MRNA during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 48.09% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BAILLIE GIFFORD & CO. Bought 21.0 Million shares of Moderna Inc
ALLIANZ GLOBAL INVESTORS U.S. LL... Bought 2.2 Million shares of Moderna Inc
CAPITAL RESEARCH & MANAGEMENT CO... Bought 1.8 Million shares of Moderna Inc